Human Thrombin activatable fibrinolysis inhibitor, TAFI ELISA Kit

6-11 business days

carboxypeptidase B2 (plasma)

CPU, PCPB, TAFI, carboxypeptidase B-like protein|carboxypeptidase B2 (plasma, carboxypeptidase U)|carboxypeptidase U|plasma carboxypeptidase B2|thrombin-activable fibrinolysis inhibitor|thrombin-act

Human

plasma, tissue homogenates

31.25 ng/mL-2000 ng/mL

7.81 ng/mL

NA

Colorimetric

1-5 hours

For research use only. Not for diagnostic procedures.

NA

Ice packs

Short term: 4°C; Long term: see manual.

The Stop Solution is acidic. Do not allow to contact skin or eyes.

Use Human Thrombin activatable fibrinolysis inhibitor, TAFI ELISA Kit before 6 months

NA

NA

NA

NA

The kit is manufactured at ISO 9001 certified facilities.

Metabolism

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.